Glybera
alipogene tiparvovec
Hyperlipoproteinemia Type I
Date of authorisation:
Revision: 8
Last updated:
MedicineHumanExpired
EMEA-000292-PIP01-08-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Cardiovascular diseases
PIP number: P/0285/2016
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001131-PIP02-12 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0029/2013
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000733-PIP02-12 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0022/2013
Route(s) of administration: Oral use
Pharmaceutical form(s):
Granules for oral suspension
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman